Preventing blood clots in cancer patients receiving outpatient care
Implementing Prevention of Venous Thromboembolism for Ambulatory Patients with Cancer (PREVenT-APC)
This study is looking at ways to help doctors better prevent blood clots in cancer patients who are not in the hospital, so they can stay safer and healthier during their treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Vermont & St Agric College NIH-funded |
| Lab location | 1 site (Burlington, United States) |
| Project ID | NIH-11094449 on NIH RePORTER |
What this research studies
This research focuses on improving the prevention of venous thromboembolism (VTE), a serious condition that can lead to death in cancer patients. It aims to develop and implement a strategy that encourages healthcare providers to assess the risk of VTE in ambulatory cancer patients and to provide appropriate preventive treatment. The study will involve creating a tailored implementation plan and testing its effectiveness compared to standard care. By understanding how to better integrate these guidelines into practice, the research seeks to enhance patient safety and outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are ambulatory cancer patients who are identified as being at high risk for venous thromboembolism.
Not a fit: Patients who are not currently undergoing cancer treatment or those who are hospitalized may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of life-threatening blood clots in cancer patients receiving outpatient treatment.
How similar studies have performed: Previous research has shown that implementing structured prevention strategies can effectively reduce VTE rates in high-risk populations, suggesting that this approach has potential for success.
Where this research is happening
Burlington, United States
- University of Vermont & St Agric College — Burlington, United States (Active)
Researchers
- Principal investigator: Martin, Karlyn — University of Vermont & St Agric College
- Study coordinator: Martin, Karlyn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.